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Objective: To evaluate the hypocholesterolemic and hypotriglyceridemic activities of
four Marrbium vulgare herb extracts using Triton WR-1339-induced hyperlipidemia in
mice.
Methods: Hyperlipidemia was developed by intraperitoneal injection of Triton (200 mg/
kg body weight). The animals were divided into main four groups of eight mice each:
normal control group, hyperlipidemic control group, hyperlipidemic plus tween-40
control and treated group. The fourth one was divided into four subgroups, petroleum
ether extract group, chloroform extract group, ethyl acetate extract group and methanol
extract treated group each of them contains two sub-sub group for treating animals with
two doses at 0.1 and 0.25 LD50.
Results: After 7 h and 24 h of treatment, the intragastric administration of all extracts
caused a signiﬁcant decrease of plasma total cholesterol. Triglyceride levels were also
signiﬁcantly lowered by all extracts while petroleum ether produced the lowest
decreasing level. Similar results were observed for LDL-cholesterol concentrations.
Furthermore, more polar extracts (methanol and ethyl acetate)-soluble fractions showed a
signiﬁcant ameliorative action on elevated atherogenic index (AI) and LDL/HDL-C ra-
tios, while these atherogenic markers were not statistically suppressed by the chloroform
and petroleum ether-soluble extract.
Conclusion: The ﬁndings indicated that Marrubium may contain polar products able to
lower plasma lipid concentrations and might be beneﬁcial in treatment of hyperlipidemia
and atherosclerosis.1. Introduction
Experimental and epidemiological studies have shown that
the plasma hypercholesterolemic state could contribute to the
development of atherosclerosis and related cardiovascular sys-
tem diseases (CVD) which are the most common cause of death
in both western and eastern societies [1].
Triton WR-1339, a non-ionic detergent (oxyethylated tertiary
octyl phenol formaldehyde polymer), has been widely used to
produce acute hyperlipidemia in animal models in order to
screen natural or chemical drugs [2] and to study cholesterol and
triacylglycerol metabolism [3]. The accumulation of plasmalipids by this detergent appears to be especially due to the
inhibition of lipoprotein lipase activity [4].
Hyperlipidemia is a highly predictive risk factor for
atherosclerosis, coronary artery diseases and cerebral vascular
diseases [5]. Coronary heart disease, stroke, atherosclerosis and
hyperlipidemia are the primary cause of death [6].
Hyperlipidemia is characterized by elevated serum total
cholesterol. Low density and very low density lipoprotein
cholesterol and decreased high density lipoprotein levels.
Hyperlipidemia associated lipid disorders are considered to
cause atherosclerotic cardiovascular disease [7].
Atherosclerosis (Sclrero-hardening) of arteries is a
generalized disease of arterial network known as a
progressive and silent killer disease characterized by the
formation of lesions called atherosclerosis plaques in the
walls of large and or medium sized coronary arteries and
reduces blood ﬂow to the myocardium called coronary artery
diseases (CAD) [8]. Hyperlipidemia is classiﬁed into article under the CC BY-NC-ND license (http://
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associated with disease. The primary disease may be treated
using anti-lipidemic drugs but the secondary type originating
from diabetes, renal lipid nephrosis or hypothyroidism de-
mands the treatment of the original disease rather than hyper-
lipidemia [9]. Medicinal plants play a major role in
hypolipidemic activity, literature suggests that the lipid
lowering action is mediated through, inhibition of hepatic
cholesterol biosynthesis and reduction of lipid absorption in
the intestine [10].
In many developing countries, most hyperlipidemic in-
dividuals use medicinal plants as folk medicine to treat
hyperlipidemia and prevent atherosclerosis. Therefore, there is
a strong interest, locally, in natural hypolipidemic substances
derived from medicinal plants. Vast numbers of plants have
received attention in this regard and have been shown to lower
plasma lipid levels [11]. Marrubium vulgare L. (M. vulgare),
white horehound, is an aromatic medicinal plant belongs to
the family Lamiaceae and native to Europe, northern Africa
and Asia [12]. Marrubiin is the main active compound
isolated from M. vulgare L., a medicinal plant used in folk
medicine to cure several diseases particularly gastroenteric
and respiratory [13]. Aqueous extract of M. vulgare L.
provides a source of natural antioxidants, which inhibit LDL
oxidation and enhance reverse cholesterol transport and thus
can prevent cardiovascular diseases development [14]. The
goal of this work is evaluation of anti-hyperlipidemic effect
of M. vulgare successive extracts in Triton WR-1339 model as
indicator for their effect on fatty acid biosynthesis and blood
lipid removal.2. Material and methods
2.1. Preparation of M. vulgare extracts
The areal parts of the cultivated M. vulgare were collected
and air dried in the shade, ground and then successively and
exhaustively extracted by gradual solvents as follows, petroleum
ether (40–60 C), chloroform, ethyl acetate and methanol. Plant
extracts were prepared by continuous extraction using soxhlet
apparatus. The four extracts were then concentrated under
reduced pressure to remove solvent completely and lyophilized
to be free from any solvent and water.
2.2. Antioxidant properties of Marrubium extracts
2.2.1. Total polyphenols content
Total polyphenols of M. vulgare extracts, petroleum ether,
chloroform, ethyl acetate and methanol, were determined by the
Folin–Ciocalteu procedure [15] to aliquots of 0.5 mL were added
0.25 mL of Folin–Ciocalteu reagent and 1.25 mL 20% aqueous
sodium carbonate solution. Samples were vortexed and
absorbance of blue colored mixtures recorded after 40 min at
725 nm against a blank containing 0.5 mL of water or 4%
DMSO in water, 0.25 mL of Folin–Ciocalteu reagent and
1.25 mL of 20% aqueous sodium carbonate solution. The
amount of total polyphenols was calculated as gallic acid
equivalents from the calibration curves of gallic acid standard
solutions and expressed as mg gallic/g dry plant extract. All
measurements were done in triplicate.2.2.2. Free radical scavenging activity
The free radical scavenging activity of M. vulgare extracts
were measured by 1, 1-diphenyl-2-picryl-hydrazil (DPPH) us-
ing the method of Yamaguchi et al., [16]. Brieﬂy, 0.1 mM
solution of DPPH in ethanol was prepared. Then, 1 mL of
this solution was added to 3 mL of M. vulgare extracts and
standards solution at different doses (50, 100, 250, 500 and
1000 mg/mL). The mixture was shaken vigorously and
allowed to stand at room temperature for 30 min. Then the
absorbance was measured at 517 nm in a spectrophotometer
(Jasco, serial No. C317961148, Japan). Lower absorbance of
the reaction mixture indicated higher free radical scavenging
activity. The reduction in DPPH radical concentration in the
reaction medium was calculated from the following equation:
DPPH scavenging effect (%) = 100 − [((A0−A1)/A0)) × 100],
whereA0was the absorbance of the control reaction andA1was the
absorbance in the presence of the sample [17].
2.2.3. Reducing power
The reducing power of marrubium extracts was determined
according to the method of [18]. M. vulgare extracts and standard
solution at different concentrations (50, 100, 250, 500 and
1000 mg/mL) in 1 mL of methanol were mixed with
phosphate buffer (2.5 mL, 0.2 M, pH 6.6) and potassium
ferricyanide [K3Fe (CN) 6] (2.5 mL, 1%). The mixture was
incubated at 50 C for 20 min. A portion (2.5 mL) of TCA
(10%) was added to the mixture, which was then centrifuged
for 10 min at 1000 × g. The upper layer of solution (2.5 mL)
was mixed with methanol (2.5 mL) and FeCl3 (0.5 mL, 0.1%),
and the absorbance was measured at 700 nm. Vitamin C was
used as a control. Higher absorbance of the reaction mixture
indicated greater reducing power.
2.2.4. Metal chelating activity
The chelating of ferrous ions by the M. vulgare extracts and
standards was estimated by the method of [19]. Brieﬂy,M. vulgare
extracts and standards solution at different concentrations (50,
100, 250, 500 and 1000 mg/mL) were added to a solution of
2 mM FeCl2 (0.05 mL). The reaction was initiated by the
addition of 5 mM ferrozine (0.2 mL) and the mixture was
shaken vigorously and left standing at room temperature for ten
minutes. After the mixture had reached equilibrium, the
absorbance of the solution was then measured
spectrophotometrically at 562 nm. The percentage of inhibition
of ferrozine-Fe2+ complex formation was given by the formula:




where A0 was the absorbance of the control, and A1 was the
absorbance in the presence of the sample of M. vulgare extracts
and standard. The control contains FeCl2 and ferrozine [20].
2.2.5. Lipid peroxidation – ammonium thiocyanate
method
The antioxidant activity of M. vulgare extracts and standards
were determined according to the method of [21] with some
modiﬁcations. A pre emulsion was prepared by mixing
175 mg Tween 20, 155 mL linoleic acid, and 0.04 M
potassium phosphate buffer (pH 7.0). A 1 mL of sample
(1 mg/mL) in 99.5% ethanol was mixed with 4.1 mL linoleic
emulsion, 0.02 M phosphate buffer (pH 7, 8 mL) and distilled
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were incubated in screw cap-tubes under dark conditions at
40 C at certain time intervals. To 0.1 mL of this mixture was
pipetted and added with 9.7 mL of 75% and 0.1 mL of 30%
ammonium thiocyanate sequentially. After 3 min, 0.1 mL of
0.02 M ferrous chloride in 3.5% hydrochloric acid was added to
the reaction mixture. The peroxide level was determined by
reading daily of the absorbance at 500 nm. Antioxidant assay of
vitamin C was also assessed for comparison. All test data was
the average of three replicate analyses. The inhibition of lipid
peroxidation in percentage was calculated by the following
equation:
% Inhibition = ½ðA0 −A1Þ=A0× 100
where A0 was the absorbance of the control reaction and A1 was
the absorbance in the presence of extracts or standard
compounds.
2.3. Acute toxicity study
The acute toxicity test for theM. vulgare gradual extracts was
carried out to evaluate any possible toxicity. Male albino mice
(n = 8) of either eight were tested by administering different
doses in intraperitoneal route of Marrubium extracts by
increasing or decreasing the dose, according to the response of
animal [22]. The dosing patron was 500, 1000, 1500, 2000,
2500, 3000 and 3500 mg/kg body weight. All groups were
observed for any gross effect or mortality during 48 h. Death
of half of examined animals was observed at 2, 2.5, 2.5 and
3 g/kg b. wt. for petroleum ether, chloroform, ethyl acetate
and methanol extracts, respectively.
2.4. Triton model of hyperlipidemia
Triton WR-1339 (Sigma–Aldrich) was dissolved in normal
saline (pH 7.4) and administered intraperitoneally to mice
(200 mg/kg B.W) in order to develop an acute hyperlipidemia in
experimental animals.
2.4.1. Animals housing
One hundred and sixty adult male albino mice, weighing 27–
30 g, bred in the animal house of National Research Centre,
Egypt, were provided ad libitum access only to tap water
throughout the experimental duration (24 h). Animals were fed
on standard diet; temperature through the housing was
controlled at 22–24 C, relative humidity (60 ± 5)% and light/
dark cycles (12/12 hrs). Animals were divided into groups and
housed in polypropylene cages; each cage was contained eight
mice adapted for one week before starting the experiment.2.4.2. Experimental design
Overnight fasted mice were randomly divided into twenty
groups of eight animals each. The ﬁrst group, serving as a
normal control (NCG), received an intraperitoneal administra-
tion of normal saline and water by gavage. The second include
two subgroups, gavaged with tween at 0.72% and 25% in saline
that used as solvents control −ve (SCG). The third, hyper-
lipidemic control group (HCG) was treated with Triton and
gavaged by distilled water. The fourth include eight treated
subgroup, animals administered Marrubium extracts at 10% and
25% of LD50 for each extract in intragastric route withintraperitoneal injection of sterilized saline, served as positive
control group. The ﬁfth group contained eight treated sub-
groups in which animals were administered Marrubium ex-
tracts at 10% and 25% of LD50 for each extract in intragastric
route with intraperitoneal injection of Triton, served as treated
group. After treatments (7 h and 24 h), animals were anaes-
thetized brieﬂy with diethyl ether and blood was taken from their
tail vein using a heparinised capillary. The blood samples were
immediately centrifuged (2500 rpm/10 min) and the plasma
were used for biochemical analysis also sera were collected for
determination of liver and kidney function.
2.4.3. Analytical procedures
Triglycerides in plasma were quantiﬁed by an enzymatic
method using Bio-diagnostic kits (Bio-diagnostic, Egypt).
Brieﬂy, after enzymatic hydrolysis with lipases, the formation of
quinoneimine from hydrogen peroxide, 4-aminophenazone and
4-chlorophenol under the catalytic effect of peroxidase, was
followed spectrophotometrically at 540 nm. Total cholesterol
levels were determined by the cholesterol oxidase enzymatic
method, using Bio-diagnostic Kits (Bio-diagnostic, Egypt);
cholesterol was hydrolyzed and, in the presence of phenol, the
quinoneimine as indicator was formed from hydrogen peroxide
and 4-aminoantipyrine via peroxidase catalysis and spectro-
photometrically measured at 510 nm. HDL-cholesterol concen-
trations were quantiﬁed by the same method as used to
determine total cholesterol after removal of other lipoproteins by
precipitation with phosphotungstic acid (PTA) and MgCl2 (Bio-
diagnostic kit, Egypt). The total lipid content was determined by
the reaction between lipids and sulfuric, phosphoric acid, and
vanillin to form pink colored complex quantiﬁed spectrophoto-
metrically at 545 nm. The LDL-cholesterol was calculated by
the Friedwald formula [23]:
LDL Cholesterol = Total cholesterol − ½HDL−Cholesterol
+ ðtriglycerides=5Þ
The atherogenic index (AI) was calculated by the following
formula:
AI = (total cholesterol − HDL-C)/HDL-C and the LDL-C/
HDL-C ratio was calculated as the ratio of plasma LDL-C to
HDL-C levels.
2.5. Statistical analysis
The results obtained in all analysis were expressed in
median ± SD (standard deviation). The levels of statistical sig-
niﬁcance (P < 0.05) were calculated based one-way ANOVA
test for comparisons among means.3. Results
3.1. Polyphenol content of M. vulgare extracts and their
antioxidant activity
The polyphenolic compounds content as mg gallic acid/g dry
plant extract of M. vulgare extracts, radical scavenging activity,
reducing power, metal chelation effect as well as lipid peroxi-
dation inhibition activity are shown in Table 1. M. vulgare ex-
tracts were scavenged DPPH radicals by different effecting
level. Methanol and ethyl acetate extracts produced the same
Table 1
Polyphenol content and antioxidant activity of M. vulgare extracts.
Plant extract Total polyphenolics content(mg/g) IC50(mg/mL)
DPPH scavenging Reduction capability Metal ion chelation Lipid peroxidation
Pet. ether ext. 30.00 ± 2.01 32.32 ± 3.10 26.57 ± 1.06 42.88 ± 2.00 78.15 ± 2.11
Chloroform ext. 140.00 ± 1.08 28.03 ± 2.57 18.41 ± 2.34 39.24 ± 1.46 73.14 ± 1.87
Ethyl acetate ext. 320.00 ± 1.91 23.57 ± 2.64a 15.49 ± 1.85b 25.46 ± 1.34c 67.04 ± 1.65
Methanol ext. 385.00 ± 1.87 22.37 ± 2.91a 13.99 ± 2.46a 24.45 ± 1.76c 50.05 ± 3.11
Vitamin C – 16.69 ± 3.06 29.00 ± 3.03 67.23 ± 1.28 85.34 ± 1.02
Data are presented IC50 ± Standard deviations, where IC50 is the concentration caused 50% inhibition, chelation or reduction. ANOVA one way was
used followed with post Hoc test for multiple comparisons. Vitamin C was used as standards. The same letter was used with insigniﬁcant differences,
P < 0.01.
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respectively) also chloroform extract and petroleum ether
showed nearly the same effect as radical scavenger (IC50 = 28
and 32 mg/mL, respectively). Methanolic extract was the most
powerful extract as reducing agent followed with ethyl acetate
extract in an insigniﬁcant difference (IC50 = 13.99 and 15.49 mg/
mL, respectively) and then chloroform extract (IC50 = 18.41 mg/
mL) while petroleum ether extract was the weak one
(IC50 = 26.57 mg/mL) but all Marrubium extract remained more
effective than vitamin C (IC50 = 29 mg/mL). The same trend of
radical scavenger results was observed with ferrous ion chela-
tion. Methanolic and ethyl acetate extracts had nearly the same
least IC50 (24.45 mg/mL and 25.46 mg/mL, respectively) fol-
lowed with chloroform extract (IC50 = 39.24 mg/mL) while
petroleum ether was the weakest extract in chelating ion metals.
These activities were reﬂected on plant extract effect on lipid
peroxidation. The most effective extracts as scavenger, reducing
agent and metal chelator were the most inhibitor for lipid per-
oxidation. Methanol and ethyl acetate extracts inhibited lipid
peroxidation with low IC50 (50.05 and 67.04 mg/mL, respec-
tively). However, chloroform produced the middle effect
(IC50 = 73.14 mg/mL) followed with petroleum ether
(IC50 = 78.15 mg/mL) and all of them were effective than
vitamin C (IC50 = 85 mg/mL). Polyphenolic content of different
plant fractions were estimated by folin reagent. The methanolic
extract contained the maximum amount of polyphenolic com-
pounds (385 mg/g) followed with ethyl acetate (320 mg/g) thenTable 2
Effect of M. vulgare extracts on lipid parameters in Triton WR-1339-induce
Groups Total
Negative control group 180.
Positive control group Tween 7% 230.
Triton(200 mg/kg) 452.
Triton and tween 7% 495.
Treated groups of different extracts at
0.1 and 0.25 LD50
Methanol extract 150.
145.




Petroleum ether extract 220.
256.
Data are presented mean of eight replicates ± Standard deviations. ANOVA
The same letter was used with insigniﬁcant differences, P < 0.01. HDL-C
cholesterol. Lipid parameters determined in mg/dL.chloroform fraction (140 mg/g) while petroleum ether had the
lowest concentration (30 mg/g).
3.2. Effect of M. vulgare extracts as hypolipidemic agent
in Triton model induced hyperlipidemia in mice
Triton and tween magnify the cholesterol production and
LDL concentration in experimental animals after 7 h from
administration while M. vulgare extracts signiﬁcantly reduced
all determined lipid parameters. Methanol extract at 0.1 and 0.25
LD50 signiﬁcantly reduced cholesterol production in hyper-
lipidemic animals (150 and 145 mg/dL) with signiﬁcant reduc-
tion in LDL (30 and 28 mg/dL) and induction of HDL
concentration (131 and 122 mg/dL) with reduction in plasma
triglyceride concentration (Table 2). The second effective extract
in inhibiting cholesterol production is ethyl acetate at the tested
two doses (165 and 164 mg/dL for 0.1 and 0.25 LD50, respec-
tively) which showed signiﬁcant decreasing in LDL level (30
and 22 mg/dL, respectively) and triglycerides level (79 and
67 mg/dL, respectively). Also, chloroform extract at 0.1 and
0.25 LD50 showed favorable effect in reducing the cholesterol
level (188 and 153 mg/dL, respectively) with signiﬁcant
reduction in triglyceride (113 and 97 mg/dL, respectively) and
decreasing LDL level (28 mg/dL) as well as signiﬁcant incre-
ment in plasma HDL (92 and 87 mg/dL). The lowest mean
values in cholesterol level were recorded with petroleum ether
extract (220 and 256 mg/dL). It is clearly that increasing pet.d hyperlipemia in mice after 7 h.
cholesterol Triglyceride HDL-cholesterol LDL-cholesterol
00 ± 5.11 60.50 ± 6.23 136.00 ± 5.15 32.50 ± 9.11
00 ± 6.42 70.00 ± 3.15 124.00 ± 4.25 50.00 ± 8.24
00 ± 4.68 300.00 ± 5.14 117.00 ± 5.13 280.00 ± 7.34
00 ± 5.78 306.00 ± 2.45 105.00 ± 4.37 295.00 ± 2.89
00 ± 4.14 71.00 ± 5.24 131.00 ± 3.61 30.00 ± 3.75
00 ± 6.17 65.00 ± 5.64 122.00 ± 4.72 28.00 ± 6.10
00 ± 6.82a 79.00 ± 4.71 116.00 ± 4.87 30.00 ± 7.14
00 ± 5.58a 67.00 ± 6.18 107.00 ± 3.25 22.00 ± 9.42
00 ± 5.38 113.00 ± 5.01 92.00 ± 5.16 28.00 ± 8.23
00 ± 4.67 97.00 ± 5.32 87.00 ± 6.37 28.00 ± 7.33
00 ± 4.88 96.00 ± 3.42 74.00 ± 3.47 33.00 ± 1.25
00 ± 8.04 100.00 ± 6.19 65.00 ± 5.18 49.00 ± 4.22
one way was used followed with post Hoc test for multiple comparisons.
: high density lipoprotein cholesterol; LDL-C: low density lipoprotein
Table 4
Effects ofM. vulgare on atherogenic index (AI) and LDL/HDL-C ratio in















Tween 7% 0.85 0.72 0.40 0.47
Triton 2.86 3.01 2.39 2.61
Triton with tween 7% 2.67 0.51 2.19 2.59
Treated
groups
Methanol extract 0.15 0.01 0.23 0.26
0.19 0.32 0.23 0.21
Ethyl acetate extract 0.42 0.19 0.19 0.33
0.53 0.07 0.28 0.24
Chloroform ether extract 1.04 0.77 0.30 0.47
0.76 0.56 0.32 0.42
Petroleum ether extract 1.97 1.39 0.45 0.51
2.94 2.14 0.75 0.85
Data are presented as mean of eight replicates ± Standard deviations,
ANOVA one way was used followed with post Hoc test for multiple
comparisons, *P<0.01. HDL-C: high density lipoprotein cholesterol;
LDL-C: low density lipoprotein cholesterol.
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this trend was true with all estimated lipid parameters. It
decreased LDL level to reach 33 mg/dl at 0.1 LD50 and reached
49 mg/dL at 0.25 LD50 while increased HDL to be 74 mg/dL at
0.1 LD50 and 65 mg/dL at 0.25 LD50.
Administration of Triton elevated animal cholesterol, tri-
glycerides and low density lipoprotein with a signiﬁcant
reduction in high density lipoprotein. However, treating
hyperlipidemic animals with methanol signiﬁcantly reduced
cholesterol after 24 h of administration (160 mg/dL at 0.1 LD50
and 116 mg/dL at 0.25 LD50) and triglycerides (104 and 95 mg/
dL for the two doses, respectively) as well as signiﬁcant
reduction in LDL-cholesterol (41.48 and 35.17 mg/dL for the
two doses, respectively) accompanied with signiﬁcant induction
in HDL-cholesterol (161 and 169.6 mg/dL for the two doses,
respectively) (Table 3). The ethyl acetate extract showed the
same effect on all assessed parameters. It increased good lipids,
HDL-cholesterol, to be near the −ve control group (146 and
157.8 mg/dL for the two doses, respectively) with signiﬁcant
reduction in cholesterol (175.6 and 168 mg/dL for the two
doses, respectively), triglycerides (100 and 90 mg/dL for two
used doses, respectively) and LDL-cholesterol (48.6 and 38 mg/
dL for two doses, respectively). Cholesterol was also decreased
to reach lower level than −ve control when animal treated with
chloroform extract at 0.1 and 0.25 LD50 (198.8 and 183 mg/dL
for the two doses, respectively). This decreasing was accom-
panied with signiﬁcant reduction in triglycerides (130 and
120 mg/dL for the low and high doses, respectively) and LDL-
cholesterol (52.49 and 49 mg/dL, respectively) as well as
favorable effect on HDL-cholesterol (112 and 117.89 mg/dL).
The petroleum ether extract produced the lower effect against
hyperlipidemia as compared to the other three extracts with the
same trend of data.
It lowered the total cholesterol in hyperlipidemic animals at
the 0.1 and 0.25 LD50 (250 and 290 mg/dL, respectively), tri-
glycerides level (200 and 255 mg/dL for the two doses,
respectively) and LDL-cholesterol (53 and 79 mg/dL, respec-
tively) with increasing the production of HDL-cholesterol level
(104 and 93 mg/dL).
The changes of atherogenic index (AI) and LDL-C/HDL-C
ratio in control and treated mice were shown in Table 4. The
Triton administration signiﬁcantly affects the cardiovascular risk
markers. Indeed, the AI was statistically increased in both tweenTable 3
Effect of M. vulgare extracts on plasma lipid parameters in Triton WR-1339
Groups Total
Negative control group 225.
Positive control group Tween 7% 223.
Triton(200 mg/kg) 538.
Triton and tween 7% 580.
Treated groups of different extracts at
0.1 and 0.25 LD50
Methanol extract 160.
116.




Petroleum ether extract 250.
292.
Data are presented as mean of eight replicates ± Standard deviations, ANO
parisons, P < 0.01. HDL-C: high density lipoprotein cholesterol; LDL-C: locontrol (0.85) and hyperlipidemic with tween group (2.67) when
compared with values found in their relative normal lipidemic
control (0.32) at 7 h. Similar results were noticed at 24 h.
Besides, there were signiﬁcant further increases of LDL-C/
HDL-C ratios in Triton-injected animals (2.39). In contrast to
normal lipidemic mice (0.24), 7 h after Triton treatment pro-
duced an elevated ratio either in hyperlipidemic group animals
(2.19) by many times. This changing pattern was maintained
until 24 h when the ratios were increased in animals compared to
normal group. Methanol extract highly reduced AI (0.15 and
0.19 for low and high doses, respectively) lower than normal
control group (0.32). The ethyl acetate extract showed the same
trend with signiﬁcant increments than methanol extract (0.42
and 0.53, respectively) with decreasing LDL-C/HDL-C ratios
(0.19 and 0.28, respectively).
The atherogenic index was lowered with chloroform
administration (1.04 and 0.76 for two doses, respectively)
accompanied with reduction in HDL/LDL-cholesterol ratio at
7 h and the same trend of data was recorded at 24 h. The
minimum recorded effect was of petroleum ether. It decreased
AI at low level of administration (1.97) didn't produce this effect-induced hyperlipemia in mice after 24 h.
cholesterol Triglyceride HDL-cholesterol LDL-cholesterol
00 ± 5.34 139.00 ± 8.31 130.00 ± 3.16 62.20 ± 5.33
00 ± 6.42 240.00 ± 8.07 110.00 ± 3.19 65.40 ± 412
50 ± 7.10 320.00 ± 7.26 108.00 ± 5.01 350.20 ± 4.08
00 ± 8.12 330.00 ± 6.18 105.00 ± 4.06 360.20 ± 6.22
00 ± 6.05 104.00 ± 6.49 161.00 ± 455 41.48 ± 7.16
90 ± 6.24 95.00 ± 7.05 169.60 ± 5.28 35.17 ± 4.35
60 ± 5.87 100.00 ± 6.66 146.80 ± 5.94 48.63 ± 3.64
20 ± 5.68 90.00 ± 5.76 157.80 ± 6.28 38.56 ± 3.87
80 ± 6.18 130.00 ± 7.017 112.14 ± 7.08 52.79 ± 7.08
90 ± 6.19 120.00 ± 6.38 117.89 ± 6.44 49.20 ± 7.06
10 ± 4.52 200.00 ± 5.49 104.45 ± 4.92 53.40 ± 6.25
20 ± 7.06 255.00 ± 7.08 93.00 ± 5.37 79.40 ± 4.95
VA one way was used followed with post Hoc test for multiple com-
w density lipoprotein cholesterol.
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cholesterol ratio (0.45 and 0.75 for two doses, respectively).
This trend was also observed at 24 h with minor increments in
values.
Data are presented as mean of eight replicates ± Standard
deviations, ANOVA one way was used followed with post Hoc
test for multiple comparisons, *P < 0.01. HDL-C: high density
lipoprotein cholesterol; LDL-C: low density lipoprotein
cholesterol.
4. Discussion
Hyperlipidemia is characterized as elevation in triglycerides
and cholesterol in the blood therefore the most plausible strategy
in prevention or treating hyperlipidemia is using drugs that
contains array of compounds which can delay fat digestion and
absorption through gastrointestinal tract by inhibiting pancreatic
lipase and pancreatic cholesterol esterase activities. The non-
ionic detergent, Triton WR-1339, has been widely used to
block the uptake of triacyl glycerol-rich lipoproteins from
plasma by peripheral tissues in order to produce acute hyper-
lipidemia in animal models which are often used for a number of
objectives, in particular for screening natural or chemical
hypolipidemic drugs [2]. With this aim, many medicinal plants
have been assessed for their hypolipidemic activity in a Triton
WR-1339-induced hyperlipidemic model [11]. This work was
aimed to assess the possible hypocholesterolemic and
hypotriglyceridemic activities of different M. vulgare extracts.
It is clear from our results that the methanolic and ethyl
acetate fractions from this plant decrease plasma total
cholesterol in a marked manner, either 7 h or 24 h after Triton
treatment. The reduction of plasma total cholesterol was
associated with a decrease of its LDL fraction which is a
major, potentially modiﬁable risk factor of cardiovascular
diseases and the target of many hypocholesterolemic therapies.
This ﬁnding suggests that the cholesterol-lowering activity of
these extracts appears to be due to the enhancement of LDL-C
catabolism, as demonstrated by [11].
It is evident from recorded results that fractions rich in
polyphenolic compounds are those ameliorate the hyper-
lipidemic effect of Triton, these ﬁndings are in accordance of
Ma¨kynen et al. [24]
Recently, a number of clinical studies suggest that the
increased risk of coronary heart disease is associated with a high
serum concentration of TC, LDL-C and triglyceride. The
abnormally high concentration of serum lipids is mainly due to
the increase in the mobilization of free fatty acids from the pe-
ripheral depots [25]. On the other hand, low serum concentration
of HDL-C is also responsible for coronary heart disease [25].
Methanolic and ethyl acetate fractions appears highly
ameliorative effect in lowering LDL and increasing HDL-
cholesterol followed with chloroform and then the lowest
effective one, petroleum ether fraction.
Preclinical observations demonstrate that hyperlipidemia
promotes accumulation of oxidatively modiﬁed low density li-
poproteins in the arterial wall, promoting endothelial dysfunc-
tion and development of atherosclerosis and congestive heart
diseases [26,27]. Polyphenolic compounds considered as health
promoting compounds that included in most functional foods
for many diseases as antihyperlipidemic and
antihyperglycemic foods [28]. The physiological effect of
polyphenolic compounds include possible antioxidant activity,therefore suggestion their role in prevention of coronary heart
disease including atherosclerosis [29]. They may also work by
making liver cells more efﬁcient to remove LDL-C from
blood by increasing the LDL-C receptor densities in liver and by
binding to apolipoprotein B [30].
The methanol and ethyl acetate fractions contained high
amount of polyphenol. On the other hand, the in-vitro antioxi-
dant estimated properties of four fractions showed the potent
effect as radical scavenger hydrogen donator and metal chelator
agent that reﬂected on their effect on inhibiting lipid peroxida-
tion. Plant fractions arranged in their activities as antioxidant had
the same pattern of activity in hyperlipidemic animals; methanol,
ethylacetate, chloroform and then petroleum ether.
Free radicals and other reactive oxygen species are consid-
ered to be important causative factors in the development of
diseases of aging such as neurodegenerative diseases, cancer and
cardiovascular diseases. Phytochemicals have long been recog-
nized to possess many properties including antioxidant, anti-
allergic, anti-inﬂammatory, antiviral, anti-proliferative and
anti-carcinogenic. This relationship has led to considerable in-
terest in assessing the antioxidant capacity of foods, botanicals
and other nutritional antioxidant supplements. As plants produce
signiﬁcant amount of antioxidants to prevent the oxidative stress
caused by photons and oxygen, they represent a potential source
of new compounds with antioxidant activity. Thus, continued
research is being undertaken all over the world on different plant
species and their therapeutic principles [31]. The four plant
fractions showed potent effect as radical scavenger when
assessed against DPPH radicals with reduction capability.
They also play as excellent metal ion chelator as they tested
against ferrous ions. These activities were accompanied with
inhibition of lipid peroxidation.
The possible mechanism of this activity may result from the
enhancement of lecithin cholesteryl acyl transferase (LCAT) and
inhibition of hepatic triglyceride lipase (HTL) on HDL which
may lead to a rapid catabolism of blood lipids through extra-
hepatic tissues [32]. It is also reported that triglycerides play a
key role in the regulation of lipoprotein interactions to
maintain normal lipid metabolism [33]. Indeed, the elevated
plasma TGs levels were associated with an increased
incidence of coronary artery disease. Moreover, these higher
plasma TG levels have been attributed mainly to an increased
population of small, dense LDL deposits which are very
atherogenic and enhanced cholesteryl ester mass transfer from
apolipoprotein B-containing lipoproteins (VLDL and LDL).
TGs have also been proposed to be a major determinant of
cholesterol esteriﬁcation, its transfer and HDL remodeling in
human plasma [34].
Methanol and ethyl acetate fractions from M. vulgare
signiﬁcantly suppressed the elevated blood concentrations of
TGs. This result suggests that the extracts are able to restore, at
least partially, the catabolism of triglycerides. The underlying
mechanism of this activity is not elucidated by the present study.
However, as hypothesized by many works with other plants
[35,36] the restoration of catabolic metabolism of triglycerides
could be due to an increased stimulation of the lipolytic
activity of plasma lipoprotein lipase (LPL).
Administration of M. vulgare provides a beneﬁcial effect on
mice lipid metabolism in regard to the reduction of AI. In fact,
the AI was deceased in fraction treated groups. This ameliorative
action was due to the plasma lipid-lowering activity of different
fractions. It is also desirable to have higher plasma HDL and
Abeer Y. Ibrahim et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(5): 453–459 459lower LDL-cholesterol to prevent atherogenesis, since there is a
positive correlation between an increased LDL-C/HDL-C ratio
and the development of atherosclerosis [37]. The results found
clearly demonstrate that the bioactive compound (s) contained
in this plant have a polar character since the polar extracts
were more active than the other extracts. These results are in
accordance with those of [14] who reported that aqueous
extract of M. vulgare L. inhibit LDL oxidation and enhance
reverse cholesterol transport with antioxidant properties which
increased the anti-atherogenic potential of HDL. Plant meth-
anol and ethyl acetate extracts possess cholesterol-suppressive
capacities and an ability to attenuate the accelerated develop-
ment of atherosclerosis in hypercholesterolemic models.
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